about
ChIA-PET tool for comprehensive chromatin interaction analysis with paired-end tag sequencingRoles, Functions, and Mechanisms of Long Non-coding RNAs in CancerAn oestrogen-receptor-α-bound human chromatin interactomeA resource of ribosomal RNA-depleted RNA-Seq data from different normal adult and fetal human tissues.Multiplex sequencing of paired-end ditags (MS-PET): a strategy for the ultra-high-throughput analysis of transcriptomes and genomes.The use of multiple displacement amplification to amplify complex DNA librariesChromatin interaction analysis using paired-end tag sequencing.Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin Interactions.Next-generation sequencing of apoptotic DNA breakpoints reveals association with actively transcribed genes and gene translocations.Large-scale functional organization of long-range chromatin interaction networksChIA-PET analysis of transcriptional chromatin interactions.Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.Targeting phosphorylation of eukaryotic initiation factor-2α to treat human disease.HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer.Deciphering Noncoding RNA and Chromatin Interactions: Multiplex Chromatin Interaction Analysis by Paired-End Tag Sequencing (mChIA-PET).Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation.Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosisRobust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene ResponsecircASXL1-1 regulates BAP1 deubiquitinase activity in leukemiaThe enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemiaInflated performance measures in enhancer-promoter interaction-prediction methodsIdentification of a novel enhancer of CEBPE essential for granulocytic differentiationMicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression
P50
Q21184100-E256B6D4-6BD4-4A06-83A7-4D41B53230FBQ26765422-A0F7D971-50A9-4B99-81CB-280F2B666956Q29541719-B51097EE-981B-4EFB-82C0-729A0E8C9DF5Q31027225-8D25CF0D-7323-4565-A231-C99CA8750947Q33250141-F53D7499-E923-483B-8F44-492FE17D974BQ33320403-F36922E3-0D19-45B3-8151-2FE68945B1C1Q33523549-758B7305-2C5F-4658-8909-599D65AF71B1Q33708447-C66D7F58-A651-4FCB-8D36-B6C08B389DCEQ34075399-F163C435-8953-46B5-920F-1F515609191EQ34275017-8101718A-1011-4D07-9FEC-44F146C965B2Q34394806-D1AB3B6B-3715-4BD7-A888-D2C898C0EF87Q37315416-74989D6A-070C-4F32-B288-33709EAE1E85Q37984829-A7DDBB17-AB14-4E66-8C9B-938338C6043EQ47379639-F9559487-2223-447C-9144-C582781C2306Q47883924-D29E7C19-7329-4002-9B01-DD72E3EBC813Q51453907-1460060A-BF75-480A-A9D2-EFEAF7962DA2Q51481805-96733DDA-4B4E-4790-B91E-19E36F7E58C1Q90644460-25EE0145-92B1-485C-B613-C4DFCB1BBE25Q91337261-1C3EC4B3-F814-4DD5-ABEA-D6A6D38CE8F7Q91525099-8E1A0C16-691A-4FC9-BC6F-9172BC8CA485Q91929019-F20B660A-1EE8-47D4-A8C8-E6957AFC9A65Q92093944-F0C1DDE4-C4D6-459C-AE99-C055CC9AD5C1Q92884610-98D50570-3422-4E34-929A-A4540F0FDEC4Q93087187-050C8514-2562-455B-B55E-625B719E7958
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Melissa J Fullwood
@ast
Melissa J Fullwood
@en
Melissa J Fullwood
@es
Melissa J Fullwood
@nl
Melissa J Fullwood
@sl
type
label
Melissa J Fullwood
@ast
Melissa J Fullwood
@en
Melissa J Fullwood
@es
Melissa J Fullwood
@nl
Melissa J Fullwood
@sl
prefLabel
Melissa J Fullwood
@ast
Melissa J Fullwood
@en
Melissa J Fullwood
@es
Melissa J Fullwood
@nl
Melissa J Fullwood
@sl
P106
P21
P31
P496
0000-0003-0321-7865